Search


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 17 (Search time: 0.018 seconds).
Item hits:
Issue DateTitleAuthor(s)
2012Cell transformation assays for prediction of carcinogenic potential: State of the science and future research needsCreton, S; Aardema, MJ; Carmichael, PL; Harvey, JS; Martin, FL; Newbold, RF; O'Donovan, MRO; Pant, K; Poth, A; Sakai, A; Sasaki, K; Scott, AD; Schechtman, LM; Shen, RR; Tanaka, N; Yasaei, H
2013The PARP-1 inhibitor Olaparib causes retention of γ-H2AX foci in BRCA1 heterozygote cells following exposure to gamma radiationBourton, EC; Plowman, PN; Harvey, AJ; Adam Zahir, S; Parris, CN
2010Differential expression of mTOR signalling components in drug resistance in ovarian cancerFoster, H; Coley, HM; Goumenou, A; Pados, G; Harvey, AJ; Karteris, E
2009Brk protects breast cancer cells from autophagic cell death induced by loss of anchorageHarvey, AJ; Pennington, C; Porter, S; Burmi, RS; Edwards, DE; Eccles, SA; Crompton, MR
2011Future therapeutic strategies: Implications for Brk targetingHarvey, AJ; Burmi, RS
2010Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancerPatani, N; Jiang, W; Newbold, R; Mokbel, K
2011Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomasCantilena, S; Pastorino, F; Pezzolo, A; Chayka, O; Pistoia, V; Ponzoni, M; Sala, A
2008Evidence of a tumour suppressive function E2F1 gene in human breast cancerNewbold, RF; Worku, D; Jouhra, F; Jiang, GW; Patani, N; Mokbel, K
2012A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastomaSottile, F; Gnemmi, I; Cantilena, S; D'Acunto, WC; Sala, A
2012Adherence to adjuvant therapy in post-menopausal breast cancer patients: A reviewBanning, M